Marwyn Value Investors Limited

Declaration of Voting Results & Voting Rights Announcements • Jun 20, 2019

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9603C

Marwyn Value Investors Limited

20 June 2019

LEI: 213800L5751QTTVEA774

20 June 2019

MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")

STATEMENT IN RELATION TO BCA MARKETPLACE PLC

The Company notes the announcement made by BCA Marketplace plc ("BCA") today in relation to a potential all cash offer to acquire the entire issued share capital of BCA at a price of 243 pence. The Marwyn Funds collectively hold 36,361,225 BCA ordinary shares, of which, as at the date of this announcement, 25,526,750 (representing 3.25% of BCA's issue share capital (excluding treasury shares)) are attributable to the Company's ordinary shareholders and 2,235,326 (representing 0.28% of BCA's issue share capital (excluding treasury shares)) are attributable to the Company's realisation shareholders.

Company enquiries:

Louisa Bonney / Scott Danks

Axio Capital Solutions Limited

Telephone: 01534 761240

Gillian Martin / Steve Pearce

Liberum Capital Limited

Telephone: 020 3100 2200

PR enquiries:

Alex Child-Villiers / Will Barker

Temple Bar Advisory Limited

Telephone: 020 7002 1080

Notes to editors:

Marwyn Value Investors Limited is a closed-ended investment company on the London Stock Exchange Specialist Fund Segment - a fully regulated market for professional, institutional and sophisticated investors. Current investments through its underlying funds include BCA Marketplace plc, Zegona Communications plc, Le Chameau Group plc, Safe Harbour Holdings plc and Wilmcote Holdings plc.

For further information see www.marwynvalue.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

MSCLLFFDRAIIFIA